| NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications A Russo, G Oliveira, S Berglund, R Greco, V Gambacorta, N Cieri, ... Blood, The Journal of the American Society of Hematology 131 (2), 247-262, 2018 | 214 | 2018 |
| Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and … N Cieri, R Greco, L Crucitti, M Morelli, F Giglio, G Levati, A Assanelli, ... Biology of Blood and Marrow Transplantation 21 (8), 1506-1514, 2015 | 157 | 2015 |
| Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant A Ruggeri, Y Sun, M Labopin, A Bacigalupo, F Lorentino, W Arcese, ... haematologica 102 (2), 401, 2017 | 149 | 2017 |
| Mechanisms of leukemia immune evasion and their role in relapse after haploidentical hematopoietic cell transplantation PE Rovatti, V Gambacorta, F Lorentino, F Ciceri, L Vago Frontiers in immunology 11, 147, 2020 | 58 | 2020 |
| Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation R Greco, F Lorentino, M Morelli, F Giglio, D Mannina, A Assanelli, ... Blood, The Journal of the American Society of Hematology 128 (11), 1528-1531, 2016 | 58 | 2016 |
| Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide A Shimoni, M Labopin, F Lorentino, MT Van Lint, Y Koc, Z Gülbas, ... Leukemia 33 (1), 230-239, 2019 | 57 | 2019 |
| Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching C Oltolini, R Greco, L Galli, D Clerici, F Lorentino, E Xue, MTL Stanghellini, ... Biology of Blood and Marrow Transplantation 26 (6), 1179-1188, 2020 | 56 | 2020 |
| The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis F Lorentino, M Labopin, K Fleischhauer, F Ciceri, CR Mueller, A Ruggeri, ... Blood Advances 1 (11), 669-680, 2017 | 55 | 2017 |
| Clinical impact of pretransplant multidrug-resistant gram-negative colonization in autologous and allogeneic hematopoietic stem cell transplantation A Forcina, F Lorentino, V Marasco, C Oltolini, M Marcatti, R Greco, ... Biology of Blood and Marrow Transplantation 24 (7), 1476-1482, 2018 | 54 | 2018 |
| Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation A Forcina, R Baldan, V Marasco, P Cichero, A Bondanza, M Noviello, ... Bone Marrow Transplantation 52 (1), 114-119, 2017 | 52 | 2017 |
| Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission F Lorentino, M Labopin, M Bernardi, F Ciceri, G Socié, JJ Cornelissen, ... American journal of hematology 93 (10), 1236-1244, 2018 | 45 | 2018 |
| Human herpesvirus 6 infection following haploidentical transplantation: immune recovery and outcome R Greco, L Crucitti, M Noviello, S Racca, D Mannina, A Forcina, ... Biology of Blood and Marrow Transplantation 22 (12), 2250-2255, 2016 | 41 | 2016 |
| Posttransplantation cyclophosphamide-and sirolimus-based graft-versus-host-disease prophylaxis in allogeneic stem cell transplant R Greco, F Lorentino, S Albanese, MTL Stanghellini, F Giglio, ... Transplantation and Cellular Therapy 27 (9), 776. e1-776. e13, 2021 | 39 | 2021 |
| Interleukin-6 as biomarker for acute GvHD and survival after allogeneic transplant with post-transplant cyclophosphamide R Greco, F Lorentino, R Nitti, MT Lupo Stanghellini, F Giglio, D Clerici, ... Frontiers in immunology 10, 2319, 2019 | 35 | 2019 |
| Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study L Vago, C Toffalori, M Ahci, V Lange, K Lang, S Todaro, F Lorentino, ... Blood 132, 818, 2018 | 31 | 2018 |
| Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia F Lorentino, M Labopin, F Ciceri, L Vago, K Fleischhauer, B Afanasyev, ... Leukemia 35 (2), 585-594, 2021 | 27 | 2021 |
| Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients R Greco, R Nitti, N Mancini, R Pasciuta, F Lorentino, ... Blood, The Journal of the American Society of Hematology 137 (11), 1556-1559, 2021 | 25 | 2021 |
| The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia D Clerici, C Oltolini, R Greco, M Ripa, F Giglio, S Mastaglio, F Lorentino, ... International Journal of Antimicrobial Agents 57 (6), 106335, 2021 | 18 | 2021 |
| Donor lymphocyte infusions after allogeneic stem cell transplantation in acute leukemia: a survey from the Gruppo Italiano Trapianto Midollo Osseo (GITMO) F Patriarca, A Sperotto, F Lorentino, E Oldani, S Mammoliti, M Isola, ... Frontiers in Oncology 10, 572918, 2020 | 18 | 2020 |
| Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients M Noviello, F Lorentino, E Xue, S Racca, G Furnari, V Valtolina, ... Blood Advances 7 (18), 5446-5457, 2023 | 16 | 2023 |
